Form 8-K
8-K — iSpecimen Inc.
Accession: 0001213900-26-087877
Filed: 2026-08-11
Period: 2026-08-06
CIK: 0001558569
SIC: 8731 (SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH)
Item: Entry into a Material Definitive Agreement
Item: Termination of a Material Definitive Agreement
Item: Financial Statements and Exhibits
Documents
8-K — ea0301317-8k_ispecimen.htm (Primary)
EX-10.1 — SETTLEMENT AGREEMENT AND MUTUAL RELEASE, DATED AS OF AUGUST 6, 2026, BY AND BETWEEN ISPECIMEN INC. AND WESTPARK CAPITAL, INC (ea030131701ex10-1.htm)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K — CURRENT REPORT
8-K (Primary)
Filename: ea0301317-8k_ispecimen.htm · Sequence: 1
false
0001558569
0001558569
2026-08-06
2026-08-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
August 6, 2026
iSpecimen Inc.
(Exact name of registrant as specified in its
charter)
Delaware
001-40501
27-0480143
(State or other jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
8 Cabot Road, Suite 1800
Woburn, MA 01801
(Address of principal executive offices, including zip code)
Registrant’s telephone number,
including area code: (781) 301-6700
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.0001 per share
ISPC
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive
Agreement.
On August 6, 2026, iSpecimen Inc. (the “Company”)
entered into a Settlement Agreement and Mutual Release (the “Settlement Agreement”) with WestPark Capital, Inc. (“WestPark”)
to resolve all disputes between them, including the arbitration captioned WestPark Capital, Inc. v. iSpecimen, Inc., JAMS Ref.
No. 5425005724 (the “Arbitration”). The Arbitration arose from engagement agreements dated on or about July 31, 2025 and October
15, 2025 (together, the “Engagement Agreements”), pursuant to which WestPark provided investment banking services to the Company,
including acting as underwriter for the Company’s underwritten public offering that closed on July 25, 2025. In the Arbitration,
WestPark asserted claims seeking damages of $269,999.91, together with interest, fees, and costs. The Company denied all liability.
Under the Settlement Agreement, the Company paid WestPark $97,500 (the “Settlement Payment”) in full satisfaction of all claims.
On August 10, 2026, WestPark filed a notice with JAMS dismissing the Arbitration and all claims asserted therein with prejudice, with
each party to bear its own fees and costs. The Settlement Agreement also provides for (i) a mutual general release of all claims between
the parties arising through the effective date of the Settlement Agreement, (ii) the termination of the Engagement Agreements in their
entirety, including any tail fee, right of first refusal, or other surviving provisions, (iii) mutual confidentiality obligations, subject
to exceptions for required regulatory and legal disclosures, and (iv) New York governing law with disputes subject to binding JAMS arbitration.
The Settlement Agreement is not an admission of liability or wrongdoing by either party. The Company expects to record the Settlement
Payment as a charge in the quarter ending September 30, 2026.
The foregoing description of the Settlement Agreement
does not purport to be complete and is qualified in its entirety by reference to the full text of the Settlement Agreement, a copy of
which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 1.02 Termination of a Material Definitive
Agreement.
As described in Item 1.01 above, the Engagement
Agreements between the Company and WestPark were terminated in their entirety effective on or about August 6, 2026, pursuant to the Settlement
Agreement. The Engagement Agreements governed WestPark’s role as underwriter for the Company’s underwritten public offering
that closed on July 25, 2025, which raised gross proceeds of approximately $4.0 million. No early termination penalties were incurred.
The information set forth in Item 1.01 above is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No.
Description
10.1
Settlement Agreement and Mutual Release, dated as of August 6, 2026, by and between iSpecimen Inc. and WestPark Capital, Inc.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
1
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: August 11, 2026
iSPECIMEN INC.
By:
/s/ Katharyn Field
Name:
Katharyn Field
Title:
Chief Executive Officer
2
EX-10.1 — SETTLEMENT AGREEMENT AND MUTUAL RELEASE, DATED AS OF AUGUST 6, 2026, BY AND BETWEEN ISPECIMEN INC. AND WESTPARK CAPITAL, INC
EX-10.1
Filename: ea030131701ex10-1.htm · Sequence: 2
Exhibit 10.1
SETTLEMENT AGREEMENT AND MUTUAL
RELEASE
This Settlement Agreement and Mutual
Release (the “Agreement”) is entered into by and between WestPark Capital, Inc. (“WestPark”) and iSpecimen, Inc. (“iSpecimen”).
WestPark and iSpecimen are referred to individually as a “Party” and collectively as the “Parties.” This Agreement
is effective as of the date of the last signature below (the “Effective Date”).
RECITALS
WHEREAS, the Parties entered into engagement
agreements dated on or about July 31, 2025 and on or about October 15, 2025 (together, the “Engagement Agreements”);
WHEREAS, WestPark commenced an arbitration
against iSpecimen before JAMS in New York, New York, captioned WestPark Capital, Inc. v. iSpecimen, Inc., JAMS Ref. No. 5425005724 (the
“Arbitration”), by a Statement of Claim asserting claims arising from the Engagement Agreements and seeking damages of $269,999.91,
together with interest, fees, and costs;
WHEREAS, iSpecimen denies any and
all liability with respect to the claims asserted in the Arbitration; and
WHEREAS, the Parties desire to fully
and finally resolve the Arbitration and all disputes between them without further expense or the uncertainty of continued proceedings;
NOW, THEREFORE, in consideration of
the mutual promises set forth below, and other good and valuable consideration, the receipt and sufficiency of which are acknowledged,
the Parties agree as follows:
1. Settlement
Payment. iSpecimen shall pay WestPark the total sum of Ninety Seven Thousand Five Hundred Dollars ($97,500.00) (the “Settlement
Payment”) within three (3) business days of the Effective Date, by wire transfer pursuant to written wire instructions to be provided
by WestPark. The Settlement Payment is inclusive of all amounts claimed in the Arbitration, including all fees, interest, costs, and expenses
of any kind. In the event iSpecimen fails to timely remit the Settlement Payment as set forth above, iSpecimen shall have (5) calendar
days from the original due date to cure such failure without any notice or demand from WestPark (the “Default Period”). If
iSpecimen fails to pay the Settlement Payment in full before expiration of the Default Period, iSpecimen shall be deemed in default of
this Agreement (a “Default”), and WestPark shall thereupon be entitled, without further notice or demand, to the full claim
amount asserted in the Arbitration, in the amount of Two Hundred Sixty-Nine Thousand Nine Hundred Ninety-Nine Dollars and Ninety-One Cents
($269,999.91), less any partial payments actually received by WestPark. Upon a Default, the Parties agree that this Agreement shall be
submitted to the JAMS arbitrator (or, if unavailable, a successor JAMS arbitrator appointed pursuant to the JAMS Rules) for entry of a
consent award in the amount of $269,999.91, less credit for any partial payments received, and the Parties stipulate that such award may
be reduced to judgment and entered in any court of competent jurisdiction pursuant to the Federal Arbitration Act and/or applicable state
law, and thereafter enforced and collected by WestPark through any lawful means, including execution, garnishment, and levy.
2. Dismissal
of the Arbitration. Within five (5) business days of WestPark’s receipt of the Settlement Payment in full, WestPark shall file
with JAMS a notice or stipulation dismissing the Arbitration and all claims asserted therein with prejudice. Each Party shall bear its
own attorneys’ fees, costs, and expenses incurred in connection with the Arbitration
and this Agreement, including any JAMS fees paid or payable by that Party.
3. Mutual
General Release. Upon WestPark’s receipt of the Settlement Payment in full, each Party, on behalf of itself and its respective
past, present, and future parents, subsidiaries, affiliates, predecessors, successors, and assigns, and each of their respective officers,
directors, managers, members, shareholders, employees, agents, attorneys, and representatives, hereby fully and forever releases, acquits,
and discharges the other Party and its respective past, present, and future parents, subsidiaries, affiliates, predecessors, successors,
and assigns, and each of their respective officers, directors, managers, members, shareholders, employees, agents, attorneys, and representatives,
from any and all claims, demands, causes of action, obligations, damages, and liabilities of every kind and nature, whether known or unknown,
suspected or unsuspected, matured or unmatured, at law or in equity, arising from the beginning of time through the Effective Date, including
without limitation all claims that were asserted or could have been asserted in the Arbitration and all claims arising out of or relating
to the Engagement Agreements. Nothing in this Section releases any Party from its obligations under this Agreement.
4. Termination
of the Engagement Agreements. The Engagement Agreements, including any tail fee, right of first refusal, or other provisions that
by their terms survive expiration or termination, are hereby terminated in their entirety, and no further amounts are or shall become
due thereunder.
5. No
Admission of Liability. This Agreement is a compromise of disputed claims. Neither this Agreement, nor the Settlement Payment,
nor any of its terms shall be construed as an admission of liability or wrongdoing by any Party, and each Party expressly denies any such
liability or wrongdoing.
6. Confidentiality.
The Parties shall keep the terms of this Agreement confidential and shall not disclose them to any third party, except: (a) to
their respective attorneys, accountants, auditors, insurers, and tax and financial advisors; (b) as required by law, regulation, subpoena,
or court or arbitral order; (c) as required by the rules or requests of any governmental or self regulatory authority, including the Securities
and Exchange Commission and FINRA, or as reasonably determined to be required under applicable securities laws and disclosure obligations;
and (d) as necessary to enforce this Agreement. This Agreement and the negotiations leading to it are subject to Rule 408 of the Federal
Rules of Evidence and all analogous state provisions.
7. Representations
and Warranties. Each Party represents and warrants that: (a) it has full power and authority to enter into this Agreement, and
the person signing on its behalf is duly authorized to do so; (b) it has not sold, assigned, transferred, or encumbered any claim released
by this Agreement; and (c) it has had the opportunity to consult with counsel of its choosing and enters into this Agreement knowingly
and voluntarily.
8. Governing
Law and Dispute Resolution. This Agreement shall be governed by and construed in accordance with the laws of the State of New
York, without regard to its conflict of laws principles. Any dispute arising out of or relating to this Agreement shall be resolved by
binding arbitration before a sole arbitrator administered by JAMS in New York, New York, pursuant to its Comprehensive Arbitration Rules
and Procedures. The prevailing party in any proceeding to enforce this Agreement shall be entitled to recover its reasonable attorneys’
fees and costs.
9. Miscellaneous.
This Agreement constitutes the entire agreement between the Parties concerning its subject matter and supersedes all prior or
contemporaneous agreements, representations, and understandings, whether written or oral. This Agreement may not be amended except in
a writing signed by both Parties. If any provision of this Agreement is held invalid or unenforceable, the remaining provisions shall
remain in full force and effect. This Agreement was jointly drafted and shall not be construed against either Party as drafter. This Agreement
is binding upon and inures to the benefit of the Parties and their respective successors and assigns. This Agreement may be executed in
counterparts, and signatures delivered by PDF, email, or electronic signature shall be deemed originals.
2
IN WITNESS WHEREOF, the Parties have executed this
Agreement as of the dates set forth below.
WESTPARK CAPITAL, INC.
By:
/s/ Frank Salvatore
Name:
Frank Salvatore
Title:
CRO
Date:
8/6/26
ISPECIMEN, INC.
By:
/s/ Katharyn Field
Name:
Katharyn Field
Title:
CEO
Date:
8/6/26
3
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 7
v3.26.1
Cover
Aug. 06, 2026
Cover [Abstract]
Document Type
8-K
Amendment Flag
false
Document Period End Date
Aug. 06, 2026
Entity File Number
001-40501
Entity Registrant Name
iSpecimen Inc.
Entity Central Index Key
0001558569
Entity Tax Identification Number
27-0480143
Entity Incorporation, State or Country Code
DE
Entity Address, Address Line One
8 Cabot Road
Entity Address, Address Line Two
Suite 1800
Entity Address, City or Town
Woburn
Entity Address, State or Province
MA
Entity Address, Postal Zip Code
01801
City Area Code
781
Local Phone Number
301-6700
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Title of 12(b) Security
Common Stock, par value $0.0001 per share
Trading Symbol
ISPC
Security Exchange Name
NASDAQ
Entity Emerging Growth Company
true
Elected Not To Use the Extended Transition Period
false
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 7A
-Section B
-Subsection 2
+ Details
Name:
dei_EntityExTransitionPeriod
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration